Welcome to the Wyoming Chapter of the American College of Cardiology
Welcome to the Wyoming Chapter of the American College of Cardiology
Please join your cardiology colleagues at the ACC Rockies Chapter Meeting in Park City, Utah for updates on ACC affairs, the potential new CV Board, and clinical topics such as Genetic and Sports EP, plus a discussion on the growing role of obesity medications in heart failure, and the first-ever Cardiology State-of-the-State report. There will be many opportunities for networking, as well!. For more information and to register, please visit:
ACC Rockies Chapter Meeting 2025
|
ACC Live Courses For a listing of all ACC Live Courses please visit: https://www.acc.org/education-and-meetings/meetings |
Latest in Cardiology from ACC.org
- CathPCI Registry Findings: PCI For Stent Thrombosis, AKI Risk and SDD, MoreRecent studies informed by data from ACC's CathPCI Registry explore trends in PCI for stent thrombosis; contrast media dosing during PCI; acute kidney injury (AKI) and same-day discharge (SDD); and disparities in use of atherectomy and intravascular lithotripsy (IVL) during PCI.
- ACCEL Lite: Cardiovascular-Kidney Therapies in CKDIn this interview, Allen J. Taylor, MD, FACC and Janani Rangaswami, MD examine “Cardiovascular-Kidney Therapies in CKDâ€.
- Pre-Hospital Glycoprotein IIb/IIIa Inhibition With Zalunfiban in STEMIThe CELEBRATE (CeleCor Blinded Randomized Trial in ST-Elevation Myocardial Infarction) trial was a phase 3, multicenter, double-blind, placebo-controlled study that evaluated the efficacy and safety of a single subcutaneous injection of zalunfiban (CeleCor Therapeutics), a novel glycoprotein IIb/IIIa inhibitor...
- ACC, AHA Release New Clinical Guideline For Managing DyslipidemiaThe new ACC/AHA Guideline on the Management of Dyslipidemia offers a comprehensive “one-stop shop†for addressing the evaluation, management and monitoring of individuals with dyslipidemias, including high blood cholesterol, hypertriglyceridemia, and elevated lipoprotein(a) (Lp[a]).
- DANCAVAS: Severe Aortic, Iliac Calcification Associated With Higher Risk of Aortic Events, MALEsSevere aortic and iliac calcification was associated with a significantly higher risk of major adverse limb events (MALEs) and aortic events, according to a prospective cohort study from the DANCAVAS trials published March 2 in Circulation. These results suggest that quantifying aortic calcification may provide valuable prognostic information and improve the risk stratification in patients […]
